Glenmede Trust CO Na Cyto Dyn Inc. Transaction History

Glenmede Trust CO Na

2 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q2 2020 Aug 14, 2020	SELL	$2.25 - $8.77 $225,000 - $877,000	-100,000 Closed	0 $0
Q4 2019 Feb 12, 2020	BUY	$0.28 - $1.0 $28,000 - $100,000	100,000 New	100,000 $100,000

406K

Ticker CYDY
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 813,040,000
Market Cap $97.6M
Description
CytoDyn Inc. operates as a clinical-stage biotechnology company. The company focuses on developing treatments for multiple therapeutic indications based on leronlimab, a novel humanized monoclonal antibody targeting the CCR5 receptor in the areas of human immunodeficiency virus (HIV), non-alcoholic steatohepatitis (NASH), oncology, and such as c...

Get notified when there are updates to the investment portfolio of Glenmede Trust CO Na, based on Form 13F filings with the SEC.

Stay updated on Glenmede Trust CO Na with notifications on news.